About 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine
4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine (PubChem CID 56950791) has the molecular formula C20H21N7O
and a molecular weight of 375.44 g/mol. Its IUPAC name is 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine.
Molecular Properties
| Compound Name | 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine |
| PubChem CID | 56950791 |
| Molecular Formula | C20H21N7O |
| Molecular Weight | 375.44 g/mol |
| Exact Mass | 375.18 |
| IUPAC Name | 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine |
| SMILES | Cc1ccc(-c2nc(N3CCOCC3)nc(-n3ccnc3C)n2)c2cc[nH]c12 |
| InChI | InChI=1S/C20H21N7O/c1-13-3-4-16(15-5-6-22-17(13)15)18-23-19(26-9-11-28-12-10-26)25-20(24-18)27-8-7-21-14(27)2/h3-8,22H,9-12H2,1-2H3 |
| InChIKey | JNFCYFOVXWKHNQ-UHFFFAOYSA-N |
| XLogP | 2.66 |
| TPSA | 84.75 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 375.44 |
| LogP ≤ 5 | 2.66 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine?
The IUPAC name of 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine (CID 56950791) is 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine.
What is the SMILES notation for 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine?
The canonical SMILES for 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine is Cc1ccc(-c2nc(N3CCOCC3)nc(-n3ccnc3C)n2)c2cc[nH]c12.
What is the InChIKey of 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine?
The InChIKey is JNFCYFOVXWKHNQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H21N7O/c1-13-3-4-16(15-5-6-22-17(13)15)18-23-19(26-9-11-28-12-10-26)25-20(24-18)27-8-7-21-14(27)2/h3-8,22H,9-12H2,1-2H3.
What are the key properties of 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine?
4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine has a molecular weight of 375.44 g/mol, XLogP of 2.66, 3 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine is sourced from PubChem (CID 56950791), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).